Table 5.

Bone Mineral Density Testing Recommendations for Men

Organization	Universal screening	Targeted screening—high risk	Risk factors
Osteoporosis Society of Canada33	No	Yes	Age over 65
			Significant height loss
			Kyphosis
			Personal history of fragility fracture after age 40
			Long-term use of glucocorticoids
			Clinical risk factors: hypogonadism, malabsorption, and primary hyperthyroidism
International Society for Clinical Densitometry34	No	Yes	Age 70 and older
			Fragility fracture
			Disease or condition associated with low bone mass or bone loss
			On medications associated with low bone mass or bone loss
Institute for Clinical Systems Improvement35	No	Yes	Fragility fracture
			Long-term glucocorticoid therapy
			Osteopenia
			Vertebral fracture
			Chronic disease/processes associated with bone loss (including pharmacotherapy with medications that cause hypogonadism)
			Prolonged hypogonadism
			Prolonged immobilization